Zhiyong Li, Jingwei Ye, Yang Liu, Kai Yao, Zhiming Wu, Yunlin Ye, Xiangdong Li, Fangjian Zhou, Zikun Ma, Liru He, Zhuowei Liu. "Final results from a phase II study of tislelizumab combined with radiotherapy as bladder-preserving treatment for high-risk non–muscle-invasive bladder cancer patients unresponsive to Bacillus Calmette-Guerin.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.4599